Fingerprint
Dive into the research topics of 'Alemtuzumab: The advantages and challenges of a novel therapy in MS'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Alemtuzumab: The advantages and challenges of a novel therapy in MS
Til Menge, Olaf Stüve, Bernd C. Kieseier, Hans Peter Hartung
Research output: Contribution to journal › Review article › peer-review
44
Scopus
citations